Analysed GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) News Sources
GenScript Sets New Benchmark for Responsible Biotech Leadership with 2025 ESG Report
14-04-2026
yahoo.com
GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
09-04-2026
yahoo.com
GenScript Biotech Corp Reports Strong FY2025 Results as Integrated Platform Strategy and Global Execution Drive High-Quality Growth
16-03-2026
yahoo.com
Genscript Biotech Corp (GNNSF) Full Year 2025 Earnings Call Highlights: Record Revenue Growth ...
16-03-2026
yahoo.com
Assessing Genscript Biotech (SEHK:1548) Valuation After Recent Share Price Volatility
03-02-2026
yahoo.com
GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San Francisco
29-01-2026
yahoo.com
GenScript is Scripting Possibilities in AI-Driven Drug Discovery as Wet-Lab Partner for Latent-X2 Innovation
28-01-2026
yahoo.com
'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week
06-01-2026
yahoo.com
Exploring the Next Era of CGT and Unlocking Limitless Possibilities: The GenScript Biotech Global Forum London 2025 Wraps Up
22-11-2025
yahoo.com
What is the current price of GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS)?
The current price of GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) is $1.42.
GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) since the previous trading day is $0.12.
GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) since the previous trading day is 9.2308%.
What is the most recent average sentiment score for GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS)?
The most recent average sentiment score for GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) is 85 out of 100.
What is the most recent average sentiment for GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS)?
The most recent sentiment for GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS) is .
SEC-8K** Filing Available For GENSCRIPT BIOTECH CORP (GNNSF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.